Aurobindo Pharma may test Rs 1430-1440: Ashish Chaturmohta

Ashish Chaturmohta of Fortune Group told CNBC-TV18, "It is very volatile in terms of broader markets and really difficult to identify stocks where there is a structural trend being formed. But definitely few stocks like Aurobindo Pharma is clearly holding the gains in last two to three weeks. If you look at it in terms of open interest build up also we have not seen a meaningful liquidation of long positions clearly indicating that the longs are holding on to their positions in the stock."

"Keeping a stop loss below Rs 1,300, the stock has the potential to cross its all-time high and can target somewhere around Rs 1,430-1,440 in next couple of trading sessions," he said.